ÌÇÐÄÆƽâ°æ

Cumulative number of biosimilars approved for marketing in the U.S. and Europe as of 2022, by year since first approval

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2022

Region

United States, EU

Survey time period

as of October 2022

Supplementary notes

* Year 8 includes US approvals through October 2022.

Citation formats

Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval

Published by A. Minhas, Oct 31, 2022
A higher number of approvals was shown in the U.S. as by the end of the ** year, the U.S. had ** biosimilars approved for marketing whereas Europe had ** biosimilars approved. This statistic shows the cumulative number of biosimilars approved for marketing in Europe and the U.S., as of **, by year since the first biosimilar was approved.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in EuropeGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPharmaceutical industry in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.